Ranitidine (Zantac) Recall

The Therapeutic Goods Administration (TGA) has recalled several products that contain the anti-reflux (heartburn) medication called ranitidine. Ranitidine is available under a number of different brand names, including Zantac, and may be known to many consumers by this name. This medicine can be supplied by prescription by a medical professional but can also be purchased without a prescription from pharmacies, supermarkets and other retailers.

The recall has occurred due to contamination with an impurity. This impurity can increase a person’s risk of cancer if they are exposed to it over many years. The risk of cancer from this impurity is very low even when ranitidine was used regularly.  The risk of cancer is extremely low if ranitidine is used for only a short-term.

If you have been prescribed ranitidine, the risk of not treating the condition may pose a greater risk to your health then the potential contamination. You should speak to you doctor about an alternative treatment.

The TGA has produced advice and information for consumers and healthcare professionals that can be found here on the TGA website